Lv11
100 积分 2024-05-23 加入
A randomized, double-blind, placebo-controlled phase II study to evaluate the efficacy and safety of ivarmacitinib (SHR0302) in adult patients with moderate-to-severe alopecia areata
3小时前
待确认
大数据时代会计信息化的风险与防范分析
1个月前
已完结
皖公网安备34019202002308
